| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On February 5, 2007
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
|
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| 2006D-0150
|
| Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and Food and Drug Administration: Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Sp
|
|
|
|
|
|
| 2006D-0413
|
| Guidance for Industry: Blue Bird Medicated Feed Labels
|
|
|
|
|
| 2006N-0036
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosur
|
|
|
|
|
|
|
|
|
| 2006N-0464
|
| Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management; Public Hearing
|
|
|
|
|
| 2006P-0243
|
| Qualified Health Claim: (QHC) Corn oil and corn oil containing foods and heart disease
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| 2007P-0042
|
| To permit an ANDA Suitability for Zolpidem Tartrate Orally-Dissolving Strips
|
|
|
|
|
| 2007P-0043
|
| To permit an ANDA Suitability for Ondansetron Orally-Dissolving Strips
|
|
| |
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| EMC 4438
|
| J. Bixby
|
| Vol #:
|
| 320
|
|
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
|
|
| EMC 668
|
| S. McHarenss
|
| Vol #:
|
| 24
|
|
| |
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
|
|
| EMC 1337
|
| M. Vecchio
|
| Vol #:
|
| 6
|
|
|
|
|
| 2002D-0325
|
| Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
|
|
|
|
|
| EMC 257
|
| J. Argade
|
| Vol #:
|
| 10
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 757
|
| B. Martini
|
| Vol #:
|
| 10
|
|
|
|
|
| EMC 758
|
| Calorie Control Council
|
| Vol #:
|
| 10
|
|
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
|
|
| EMC 101
|
| K. Smith
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 102
|
| T. Goldbach
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
| |
|
| EMC 103
|
| S. Merten
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 104
|
| S. Dunn
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 105
|
| Q. Quartararo
|
| Vol #:
|
| 5
|
|
| |
|
| 2004D-0369
|
| Recommendations for the Early Food Safety Evaluation of New Non-Pesticidal Proteins Produced by Bioengineered Plants Intended for Food Use
|
|
|
|
|
| EC 520
|
| N/A
|
| Vol #:
|
| 17
|
|
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
|
|
| EMC 4212
|
| M. Artus
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4213
|
| K. Marohn
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4214
|
| K. & L. Peters
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4215
|
| P. Chamberlin
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4216
|
| S. Williams
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4217
|
| T. Mundell
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4218
|
| N. Wilcox
|
| Vol #:
|
| 199
|
|
|
|
|
| EMC 4219
|
| C. Boyles
|
| Vol #:
|
| 199
|
|
|
|
|
| 2006D-0150
|
| Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and Food and Drug Administration: Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Sp
|
|
|
|
|
|
|
|
|
|
|
| EC 6
|
| N/A
|
| Vol #:
|
| 1
|
|
| |
|
| 2006D-0413
|
| Guidance for Industry: Blue Bird Medicated Feed Labels
|
|
|
|
|
| EMC 1
|
| J. Morris
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0036
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosur
|
|
|
|
|
|
|
|
|
|
|
| EMC 17
|
| No Submitter
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 18
|
| M. White
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 19
|
| V. Emery
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 20
|
| S. Frayne
|
| Vol #:
|
| 1
|
|
|
|
|
| EMC 21
|
| B. Froehlin
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006N-0464
|
| Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management; Public Hearing
|
|
|
|
|
| TR 1
|
| Transcript of the 12/18/06 Public Meeting
|
| Vol #:
|
| 3
|
|
|
|
|
| 2006P-0243
|
| Qualified Health Claim: (QHC) Corn oil and corn oil containing foods and heart disease
|
|
|
|
|
| EMC 1
|
| The Wood Burditt Group
|
| Vol #:
|
| 11
|
|
|
|
|
| 2006P-0415
|
| Petition Seeking Regulation of Cloned Animals
|
|
|
|
|
| EMC 65
|
| M. Buckner
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
| |
|
| EMC 66
|
| P. Randall
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 67
|
| E. Ure
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 68
|
| S. Billig
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 69
|
| J. Hessen
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 70
|
| H. Young
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 71
|
| L. Bagley
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 72
|
| C. Sullivan
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 73
|
| M. Curmaskie
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 74
|
| M. Boosinger
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 75
|
| L. Decker
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 76
|
| C. Lampe
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 77
|
| M. Harris
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 78
|
| P. Muldoon
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 79
|
| B. Flowers
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 80
|
| B. Rodgers
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 81
|
| P. Allamong
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 82
|
| A. Hew
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 83
|
| D. Matesz
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 84
|
| P. Bradshaw
|
| Vol #:
|
| 5
|
|
|
|
|
| EMC 85
|
| J. Weiss
|
| Vol #:
|
| 5
|
|
|
|
|
| 2006P-0508
|
| Make 2 to 5 milligram pills of Naltrexone to have over-the-counter status
|
|
|
|
|
| EMC 1
|
| C. Weber
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0042
|
| To permit an ANDA Suitability for Zolpidem Tartrate Orally-Dissolving Strips
|
|
|
|
|
| ACK 1
|
| FDA / DDM to Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2007P-0043
|
| To permit an ANDA Suitability for Ondansetron Orally-Dissolving Strips
|
|
|
|
|
| ACK 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
